BiotechTube
Home/Neuroptika/Tim Min (민현석)
TM

Tim Min (민현석)

Co-CEO

Neuroptika

Therapeutic Areas

OphthalmologyRetinal Diseases

Neuroptika Pipeline

DrugIndicationPhase
NRO-CMKNeurodegenerative (Normal-Tension) GlaucomaPreclinical
NRO-VTNDry Age-Related Macular Degeneration (AMD)Preclinical
Undisclosed ProgramWet AMD & Diabetic RetinopathyResearch

Leadership Team at Neuroptika

TP
Taeksang Park (박택상)
Co-CEO
View full Neuroptika profile